CN Patent

CN102762098B — 组合

Assigned to NOVA LABORATORIES Sdn Bhd · Expires 2015-10-14 · 11y expired

What this patent protects

本发明涉及治疗人癌症的方法，以及涉及用于这种治疗的药物组合。具体地，该方法涉及癌症治疗方法，包括向有此需要的人给药N-{3-[3-环丙基-5-(2-氟-4-碘-苯基氨基)-6,8-二甲基-2,4,7-三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其可药用盐或溶剂化物和N-{(1S)-2-氨基-1-[(3-氟苯基)甲基]乙基}-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)-2-噻吩甲酰胺或其可药用盐。

USPTO Abstract

本发明涉及治疗人癌症的方法，以及涉及用于这种治疗的药物组合。具体地，该方法涉及癌症治疗方法，包括向有此需要的人给药N-{3-[3-环丙基-5-(2-氟-4-碘-苯基氨基)-6,8-二甲基-2,4,7-三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺或其可药用盐或溶剂化物和N-{(1S)-2-氨基-1-[(3-氟苯基)甲基]乙基}-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)-2-噻吩甲酰胺或其可药用盐。

Drugs covered by this patent

trametinib-dimethyl-sulfoxide (TRAMETINIB DIMETHYL SULFOXIDE)

Patent Metadata

Patent number: CN102762098B
Jurisdiction: CN
Classification: —
Expires: 2015-10-14
Drug substance claim: No
Drug product claim: No
Assignee: NOVA LABORATORIES Sdn Bhd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.